about
Silencing relaxin-3 in nucleus incertus of adult rodents: a viral vector-based approach to investigate neuropeptide functionThe chemistry and biology of human relaxin-3.Relaxin' the brain: a case for targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders.Relaxin-3/RXFP3 Signaling and Neuroendocrine Function - A Perspective on Extrinsic Hypothalamic Control.Relaxin family peptides and receptors in mammalian brain.Nucleus incertus--an emerging modulatory role in arousal, stress and memory.Relaxin-3 systems in the brain--the first 10 years.Comparative localization of leucine-rich repeat-containing G-protein-coupled receptor-7 (RXFP1) mRNA and [33P]-relaxin binding sites in rat brain: restricted somatic co-expression a clue to relaxin action?Ascending control of arousal and motivation: role of nucleus incertus and its peptide neuromodulators in behavioural responses to stress.Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain.Development of a Single-Chain Peptide Agonist of the Relaxin-3 Receptor Using Hydrocarbon Stapling.Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.Nucleus incertus promotes cortical desynchronization and behavioral arousal.Comparative Distribution of Relaxin-3 Inputs and Calcium-Binding Protein-Positive Neurons in Rat Amygdala.Anxiogenic drug administration and elevated plus-maze exposure in rats activate populations of relaxin-3 neurons in the nucleus incertus and serotonergic neurons in the dorsal raphe nucleus.Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation.Modulation of hippocampal theta oscillations and spatial memory by relaxin-3 neurons of the nucleus incertus.Distribution and targets of the relaxin-3 innervation of the septal area in the rat.Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus.Electrolytic lesion of the nucleus incertus retards extinction of auditory conditioned fear.Localization of LGR7 (relaxin receptor) mRNA and protein in rat forebrain: correlation with relaxin binding site distribution.Dual-transmitter systems regulating arousal, attention, learning and memory.Verification of a relaxin-3 knockout/LacZ reporter mouse as a model of relaxin-3 deficiency.Distribution of relaxin-3 mRNA and immunoreactivity and RXFP3-binding sites in the brain of the macaque, Macaca fascicularis.Structure and activity in the relaxin family of peptides.Localization of relaxin-3 in brain of Macaca fascicularis: identification of a nucleus incertus in primate.Relaxin receptor activation in the basolateral amygdala impairs memory consolidation.Septal projections to nucleus incertus in the rat: bidirectional pathways for modulation of hippocampal function.Localization of LGR7 gene expression in adult mouse brain using LGR7 knock-out/LacZ knock-in mice: correlation with LGR7 mRNA distribution.Relaxin-3: Improved Synthesis Strategy and Demonstration of Its High-Affinity Interaction with the Relaxin Receptor LGR7 BothIn VitroandIn Vivo†Gram scale preparation of clozapine -oxide (CNO), a synthetic small molecule actuator for muscarinic acetylcholine DREADDs
P50
Q27326541-CDBAE403-27FB-42C0-8565-74321C4263B3Q30992109-189CA4DA-89B4-4E78-BF09-AFFB02B51791Q33606810-9F8AED17-2F3B-4F8B-BECF-920C4733D33BQ37180057-6B41B921-452D-4A60-9402-BC9B804B3EB3Q37470781-444E0F8E-F718-46A6-A910-35277533CC87Q37844209-FB9995A9-BA21-45CA-844A-63DD0538BF9CQ37892700-63C0A2E9-D430-45AB-AF7B-11708BE2C96EQ38312904-FDE37656-7D35-4B72-835A-20E5DF3D0874Q38328638-216FDB25-8340-429D-A00F-4E77606107E7Q38341384-8BD74AD7-F9BC-4DA8-AC83-95351A500910Q38755370-53380C32-247D-4C2C-A1A8-F104E22F1498Q38806835-E4D9A597-26A9-415C-9C84-FA124358F812Q39749193-3E9D6D80-862F-4565-B006-529996EF2FDFQ39930318-E7FA4624-F473-48F0-8E9B-EFAB59D6654DQ40769700-6C046582-4412-4552-ACF5-CBE0EE4D3691Q42456119-E9094DA4-E26A-42EA-B065-FE092B78030EQ43251120-3D4238EB-5DB9-4E17-A1A2-5E3D5D7A9860Q45160898-789DEAB8-DAF2-4F4B-8114-EE54120F9FD2Q45882999-9DD03717-8CD9-4EA2-8516-17BAAF07D911Q46467162-1EFBB97D-D750-4D3B-B889-1762EB542562Q46547368-508A569B-62C0-4179-850E-4D9C2E004A3AQ47657713-B337B26B-5F2D-4E45-9868-1F2E33D4968DQ47879551-7969A269-E986-4AA1-A09D-3912E795958AQ47879567-F679D8DD-6286-4D29-ADE4-75DD6995600DQ47880013-8448DA67-0312-40EC-A21F-465E6255F481Q48428716-F54F0F5C-F067-4767-A29B-7351686AE987Q48468730-7127286B-2399-4A1B-A809-D1630F7E4E0FQ48504624-BAB3E950-AF48-48B4-9AF8-90E6C9771FBEQ48853808-0F620AD8-2E25-4218-81C1-14035C04B47AQ58208787-3E7FF002-B27B-40E7-9F8A-63D25FB013BAQ63363119-3ABA2D32-E90E-481C-A4DA-B5A45DFCFF9C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sherie Ma
@ast
Sherie Ma
@en
Sherie Ma
@es
Sherie Ma
@nl
Sherie Ma
@sl
type
label
Sherie Ma
@ast
Sherie Ma
@en
Sherie Ma
@es
Sherie Ma
@nl
Sherie Ma
@sl
prefLabel
Sherie Ma
@ast
Sherie Ma
@en
Sherie Ma
@es
Sherie Ma
@nl
Sherie Ma
@sl
P106
P1153
9036792400
P31
P496
0000-0003-3597-9522